BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3624802)

  • 1. Chemotherapy of thyroid carcinoma.
    Ahuja S; Ernst H
    J Endocrinol Invest; 1987 Jun; 10(3):303-10. PubMed ID: 3624802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.
    De Besi P; Busnardo B; Toso S; Girelli ME; Nacamulli D; Simioni N; Casara D; Zorat P; Fiorentino MV
    J Endocrinol Invest; 1991 Jun; 14(6):475-80. PubMed ID: 1723086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for thyroid cancer.
    Hoskin PJ; Harmer C
    Radiother Oncol; 1987 Nov; 10(3):187-94. PubMed ID: 2448847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.
    Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I
    Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of highly malignant thyroid tumors].
    Kober F; Heiss A; Keminger K; Depisch D
    Wien Klin Wochenschr; 1990 Apr; 102(9):274-6. PubMed ID: 2165340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study.
    Scherübl H; Raue F; Ziegler R
    J Cancer Res Clin Oncol; 1990; 116(1):21-3. PubMed ID: 2312602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and multimodality treatment in thyroid carcinoma.
    Ekman ET; Lundell G; Tennvall J; Wallin G
    Otolaryngol Clin North Am; 1990 Jun; 23(3):523-7. PubMed ID: 1694985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].
    Droz JP; Rougier P; Goddefroy V; Schlumberger M; Gardet P; Parmentier C
    Bull Cancer; 1984; 71(3):195-9. PubMed ID: 6541515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy with adriamycin, cisplatin and vindesine in C cell carcinoma of the thyroid].
    Scherübl H; Raue F; Ziegler R
    Onkologie; 1990 Jun; 13(3):198-202. PubMed ID: 2204006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy for giant cell carcinoma of the thyroid.
    Spanos GA; WolK D; Desner MR; Khan A; Platt N; Khafif RA; Cortes EP
    Cancer; 1982 Dec; 50(11):2252-6. PubMed ID: 6182970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
    Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
    Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of thyroid malignomas (author's transl)].
    Reinwein D
    Strahlentherapie; 1978 Jun; 154(6):365-7. PubMed ID: 78550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of medullary thyroid carcinomas and carcinoid tumors to adriamycin.
    Ravry MJ
    Cancer Treat Rep; 1977; 61(1):106-7. PubMed ID: 861958
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.
    Gottlieb JA; Hill CS
    N Engl J Med; 1974 Jan; 290(4):193-7. PubMed ID: 4808917
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy.
    Husain M; Alsever RN; Lock JP; George WF; Katz FH
    Horm Res; 1978; 9(1):22-5. PubMed ID: 618781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of chemotherapy in thyroid cancer].
    Benker G; Reinwein D
    Dtsch Med Wochenschr; 1983 Mar; 108(11):403-6. PubMed ID: 6186447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy of undifferentiated thyroid neoplasms; chemotherapy].
    Tsutsui K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1196-201. PubMed ID: 9379099
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
    Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
    Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.